Jeremie Calais

20PUBLICATIONS
98CO-AUTHORS
Radiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 18, 2026
Liver Background Uptake of Prostate-specific Membrane Antigen-targeted PET Radiotracers: A Systematic Review and Meta-Analysis.

|Apr 03, 2026
Virchow Node in Prostate Cancer.

Adrien Holzgreve, Jeremie Calais

|Mar 18, 2026
Reply to: Comments on the LUNAR Trial in Oligorecurrent Hormone-Sensitive Prostate Cancer.

Luca F Valle, Jeremie Calais, Amar U Kishan

|Mar 04, 2026
131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study.

Evan Y Yu, Vivek Narayan, Giuseppe Esposito

|Nov 12, 2025
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study.

Amar U Kishan, Luca F Valle, Holly Wilhalme

|Nov 14, 2024
Molecular imaging of renal cell carcinomas: ready for prime time.

Qianyun Wu, Hongda Shao, Wei Zhai

Pageof 4

Frequent Collaborators

3 joint publications

Mattias Eiber

3 joint publications

Luca F Valle

3 joint publications

Amar U Kishan

3 joint publications

Howard I Scher